MetLife, Inc. $MET Shares Sold by Compagnie Lombard Odier SCmA

Key Points

• Compagnie Lombard Odier SCmA reduced its stake in MetLife, Inc. by 41.0%, selling 124,110 shares during the 2nd quarter, and now holds 178,784 shares valued at approximately $14.38 million.
• MetLife's stock price is currently around $81.07, showing a 2.4% increase, while the company has a market cap of $53.91 billion and reported $2.02 EPS, falling short of estimates.
• The company announced a $0.5675 quarterly dividend, with an annualized yield of 2.8%, and has seen substantial changes in institutional holdings, with institutional investors owning 94.99% of its stock.

Compagnie Lombard Odier SCmA trimmed its position in MetLife, Inc. (NYSE:MET - Free Report) by 41.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 178,784 shares of the financial services provider's stock after selling 124,110 shares during the period. Compagnie Lombard Odier SCmA's holdings in MetLife were worth $14,378,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. North Capital Inc. acquired a new position in MetLife in the 1st quarter valued at $26,000. Motco boosted its position in MetLife by 105.5% during the first quarter. Motco now owns 413 shares of the financial services provider's stock worth $33,000 after acquiring an additional 212 shares during the last quarter. Abound Wealth Management grew its stake in MetLife by 652.3% during the 2nd quarter. Abound Wealth Management now owns 489 shares of the financial services provider's stock valued at $39,000 after acquiring an additional 424 shares in the last quarter. WPG Advisers LLC acquired a new stake in MetLife in the 1st quarter valued at about $46,000. Finally, American National Bank & Trust lifted its stake in MetLife by 128.4% in the 1st quarter. American National Bank & Trust now owns 603 shares of the financial services provider's stock worth $48,000 after purchasing an additional 339 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company's stock.

MetLife Stock Up 2.4%

MetLife stock opened at $81.07 on Tuesday. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The stock has a market cap of $53.91 billion, a PE ratio of 13.74, a P/E/G ratio of 0.71 and a beta of 0.87. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. The stock's fifty day moving average is $78.37 and its two-hundred day moving average is $78.08.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing the consensus estimate of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to analysts' expectations of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.MetLife's revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.28 EPS. On average, sell-side analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th were given a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend was Tuesday, August 5th. MetLife's dividend payout ratio (DPR) is 38.47%.

Analysts Set New Price Targets

Several research firms recently commented on MET. JPMorgan Chase & Co. increased their price target on MetLife from $86.00 to $95.00 and gave the company an "overweight" rating in a report on Tuesday, July 8th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $97.00 price target (up previously from $94.00) on shares of MetLife in a research report on Thursday, July 10th. Wolfe Research upgraded MetLife to a "strong-buy" rating in a research report on Tuesday, September 16th. Piper Sandler downgraded MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 target price on the stock. in a research report on Friday. Finally, Keefe, Bruyette & Woods lowered their price target on MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a report on Monday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $94.64.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.